Open AccessFecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease
Author(s) -
Heidi Kammerlander,
Jan Nielsen,
Jens Kjeldsen,
Torben Knudsen,
Kim Oren Gradel,
Sonia Friedman,
Bente Mertz Nørgård
Publication year - 2018
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izx055
Subject(s) - medicine , calprotectin , pregnancy , inflammatory bowel disease , gastroenterology , biomarker , cohort , confidence interval , disease , obstetrics , biochemistry , chemistry , biology , genetics
Fecal calprotectin (FC) is a biomarker used for assessing disease activity among IBD patients. Sparse knowledge exists as to whether FC correlates with clinical disease activity during pregnancy. Our aim was to assess FC and selected biomarkers in women with moderate-severe IBD and correlate them with clinical disease activity scores in pregnant women.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom